THIN STAGE-I PRIMARY CUTANEOUS MALIGNANT-MELANOMA - COMPARISON OF EXCISION WITH MARGINS OF 1 OR 3 CM

被引：392

作者：

VERONESI, U

CASCINELLI, N

ADAMUS, J

BALCH, C

BANDIERA, D

BARCHUK, A

BUFALINO, R

CRAIG, P

DEMARSILLAC, J

DURAND, JC

VANGEEL, AN

HOLMSTROM, H

HUNTER, JA

JORGENSEN, OG

KISS, B

KROON, B

LACOUR, J

LEJEUNE, F

MACKIE, R

MECHL, Z

MITROV, G

MORABITO, A

NOSEK, H

PANIZZON, R

PRADE, M

SANTI, P

VANSLOOTEN, E

TOMIN, R

TRAPEZNIKOV, N

TSANOV, T

URIST, M

WOZNIAK, KD

机构：

[1] NATL CANC INST, DIV SURG ONCOL, VIA VENEZIAN 1, I-20133 MILAN, ITALY

[2] INST ONCOL, PL-44100 GLIWICE, POLAND

[3] UNIV ALABAMA, MED CTR, BIRMINGHAM, AL 35294 USA

[4] HOSP AC CAMARGO, SAO PAULO, BRAZIL

[5] NN PETROV ONCOL RES INST, LENINGRAD 188646, USSR

[6] NETHERLANDS CANC INST, 1066 CX AMSTERDAM, NETHERLANDS

[7] CHRISTIE HOSP & HOLT RADIUM INST, MANCHESTER M20 9BX, LANCS, ENGLAND

[8] INST NACL CANC, RIO DE JANEIRO, RJ, BRAZIL

[9] FDN CURIE, F-75231 PARIS 05, FRANCE

[10] THERAPEUT RADIO INST, ROTTERDAM, NETHERLANDS

[11] UNIV HOSP ZURICH, DERMATOL KLIN, CH-8091 ZURICH, SWITZERLAND

[12] GOTHENBURG UNIV, S-41124 GOTHENBURG, SWEDEN

[13] ROYAL INFIRM EDINBURGH, EDINBURGH EH3 9HB, MIDLOTHIAN, SCOTLAND

[14] NORWEGIAN RADIUM HOSP, OSLO 3, NORWAY

[15] STATE INST ONCOL, BUDAPEST, HUNGARY

[16] INST GUSTAVE ROUSSY, F-94805 VILLEJUIF, FRANCE

[17] INST JULES BORDET, B-1000 BRUSSELS, BELGIUM

[18] UNIV GLASGOW, GLASGOW G12 8QQ, SCOTLAND

[19] ONCOL RES INST, BRNO, CZECHOSLOVAKIA

[20] ONCOL RES INST, SOFIA, BULGARIA

[21] ONCOL INST, CRACOW, POLAND

[22] ONCOL INST, GENOA, ITALY

[23] INST ONCOL, BELGRADE, YUGOSLAVIA

[24] ACAD MED SCI USSR, CANC RES CTR, MOSCOW 109801, USSR

[25] MARTIN LUTHER UNIV, DDR-4010 HALLE, GER DEM REP

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 1988年 / 318卷 / 18期

关键词：

D O I：

10.1056/NEJM198805053181804

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1159 / 1162

页数：4

共 17 条

[1] AITKEN DR, 1984, ARCH SURG-CHICAGO, V119, P643
[2] BALCH CM, 1979, CANCER, V43, P883, DOI 10.1002/1097-0142(197903)43:3<883::AID-CNCR2820430316>3.0.CO
[3] 2-V
[4] TUMOR THICKNESS, LEVEL OF INVASION AND NODE DISSECTION IN STAGE-1 CUTANEOUS MELANOMA
BRESLOW, A
[J]. ANNALS OF SURGERY, 1975, 182 (05) : 572 - 575
[5] BRESLOW A, 1977, SURG GYNECOL OBSTET, V145, P691
[6] CASCINELLI N, 1980, EUR J CANCER, V16, P1079
[7] CLARK WH, 1969, CANCER RES, V29, P705
[8] COSIMI AB, 1984, CANCER, V53, P1256
[9] NARROWER MARGINS FOR CLINICAL STAGE-I MALIGNANT-MELANOMA
DAY, CL
MIHM, MC
SOBER, AJ
FITZPATRICK, TB
MALT, RA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (08) : 479 - 482
[10] OPTIMAL RESECTION MARGIN FOR CUTANEOUS MALIGNANT-MELANOMA
ELDER, DE
GUERRY, D
HEIBERGER, RM
LAROSSA, D
GOLDMAN, LI
CLARK, WH
THOMPSON, CJ
MATOZZO, I
VANHORN, M
[J]. PLASTIC AND RECONSTRUCTIVE SURGERY, 1983, 71 (01) : 66 - 72

← 1 2 →